Self-discrepancy theory is a model of self-regulation and affect which predicts people's emotional states as a function of self-perceived progress toward important goals. This study will demonstrate how the emotional and physiological consequences of self-regulatory cognition can influence-susceptibility to upper respiratory illness in college-age women. A series of four studies will be conducted examining the impact of self-discrepancy, negative effect, and menstrual dysfunction on the incidence and severity of colds and flu, via the mediating influence of immunological changes. Study 1 will replicate and extend our previous demonstration of the acute emotional, hormonal, and immune consequences of self-regulatory cognition, comparing the responses of serf-discrepant women (with and without menstrual dysfunction) vs. controls to a priming manipulation involving their own unattained self-standards. Study 2 is a prospective investigation of the incidence and severity of colds and flu, conducted over a six-month period of the academic year that includes two naturalistic challenges: the onset of the cold/flu season and final exams. Study 3 will validate the self-report findings of Study 2 by measuring antibodies to influenza virus in high-risk (high self-discrepancy menstrual dysfunction) and low-risk (low self-discrepancy no menstrual dysfunction) women randomized to receive or not receive a flu vaccine and then followed for six months. Again focusing on high-risk and low-risk women, Study 4 will test a brief intervention modeled after Pennebaker's studies of writing about emotional experiences.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR003186-15
Application #
6413098
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
1994-12-01
Project End
2004-11-30
Budget Start
Budget End
Support Year
15
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Burgess-Hull, Albert J; Roberts, Linda J; Piper, Megan E et al. (2018) The social networks of smokers attempting to quit: An empirically derived and validated classification. Psychol Addict Behav 32:64-75
Kelly, Elizabeth A; Esnault, Stephane; Liu, Lin Ying et al. (2017) Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma. Am J Respir Crit Care Med 196:1385-1395
Shen, Zhong-Jian; Hu, Jie; Kashi, Venkatesh P et al. (2017) Epstein-Barr Virus-induced Gene 2 Mediates Allergen-induced Leukocyte Migration into Airways. Am J Respir Crit Care Med 195:1576-1585
Anderson, Halie M; Lemanske Jr, Robert F; Evans, Michael D et al. (2017) Assessment of wheezing frequency and viral etiology on childhood and adolescent asthma risk. J Allergy Clin Immunol 139:692-694
Gomez, Jose L; Yan, Xiting; Holm, Carole T et al. (2017) Characterisation of asthma subgroups associated with circulating YKL-40 levels. Eur Respir J 50:
Kelly, Elizabeth A; Esnault, Stephane; Johnson, Sean H et al. (2016) Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. Immunol Cell Biol 94:701-8
Bray, Bethany C; Smith, Rachel A; Piper, Megan E et al. (2016) Transitions in Smokers' Social Networks After Quit Attempts: A Latent Transition Analysis. Nicotine Tob Res 18:2243-2251
Dougherty, Ryan J; Ellingson, Laura D; Schultz, Stephanie A et al. (2016) Meeting physical activity recommendations may be protective against temporal lobe atrophy in older adults at risk for Alzheimer's disease. Alzheimers Dement (Amst) 4:14-7
Johansson, Mats W; Evans, Michael D; Crisafi, Gina M et al. (2016) Serum periostin is associated with type 2 immunity in severe asthma. J Allergy Clin Immunol 137:1904-1907.e2
Gerald, Joe K; Gerald, Lynn B; Vasquez, Monica M et al. (2015) Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma. J Allergy Clin Immunol Pract 3:540-6.e3

Showing the most recent 10 out of 459 publications